HealthIT Answers September 27, 2023
Vid Desai

The U.S. Food and Drug Administration has released its comprehensive FDA Information Technology Strategy for Fiscal Years 2024 to 2027 (IT Strategy), marking a defining roadmap for the agency’s technological advancement and the alignment with its broader public health mission. The IT Strategy fulfills commitments under the FDA’s Prescription Drug User Fee Act (PDUFA VII) reauthorization for fiscal years (FYs) 2023-2027 and obligations under section 3627 of the Food and Drug Omnibus Reform Act of 2022 (“FDORA”) as part of the Consolidated Appropriations Act, 2023. Led by the FDA’s Office of Digital Transformation with input from FDA centers and external stakeholders, the plan is both ambitious and collaborative, designed to meet the diverse needs of its internal and external constituents.


Today's Sponsors


Today's Sponsor


Topics: FDA, Govt Agencies, Health IT, Technology
8 most influential drug approvals in 2023: GoodRx
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
FDA Establishes Advisory Committee for Digital Health Technology
FemTech: Mosie Baby Awarded FDA Clearance for At-Home Intravaginal Insemination
Novartis gets FDA approval of closely watched rare disease drug

Share This Article